September 19, 2023
The Centers for Disease Control and Prevention (CDC) has awarded $17.5 million to a coalition led by researchers at UC San Diego to develop innovative tools and networks to respond rapidly to emerging disease outbreaks.
July 25, 2018
In a study published online July 25 in the journal Nature, University of California San Diego School of Medicine researchers identified a signaling pathway that activates the NLRP3 inflammasome implicated in several severe chronic inflammatory disorders.
March 19, 2012
…prevents it from reproducing. Hepatitis C is a chronic infectious disease that affects some 170 million people worldwide and causes chronic liver disease and liver cancer.
June 6, 2016
To better understand the pathogenic bacteria Staphylococcus aureus and develop more effective treatments, University of California San Diego researchers examined the Staph “pan-genome” — the genomes of 64 different strains that differ in where they live, the types of hosts they infect and their antibiotic resistance profiles. This effort, published…
March 26, 2020
…UC San Diego. “For disease prevention, robot-controlled noncontact ultraviolet (UV) surface disinfection has already been used because COVID-19 spreads not only from person to person via close contact respiratory droplet transfer but also via contaminated surfaces,” the researchers write. “Opportunities lie in intelligent navigation and detection of high-risk, high-touch areas,…
July 4, 2016
…everything from autism to infectious diseases. Yet genomic studies in mice have lagged behind those in humans. In a study, researchers at University of California San Diego School of Medicine used 1,200 outbred mice, which are more similar to a natural population, to test a new cost-effective technique to search…
July 18, 2022
UC San Diego researchers tracked the evolution of a gene variant that supports cognitive health in older humans, but may have first emerged to protect against bacteria.
May 16, 2012
UC San Diego biologists have produced a potential malarial vaccine from algae, an achievement that could pave the way for the development of an inexpensive way to protect billions of people from the disease.
April 12, 2016
…Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) to establish an interdisciplinary center to define the systems biology of antibiotic resistance. The program will be led by Bernhard Palsson, PhD, Distinguished Professor of Bioengineering and Pediatrics, and Victor Nizet, MD, professor of pediatrics and pharmacy.
March 1, 2021
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
